Acil Serviste Warfarin (Coumadin) Toksisitesi Tanı ve Tedavi Yaklaşımı
References
Chapman SA, Irwin ED, Beal AL, et al. Prothrombin complex concentrate versus standard the- rapies for INR reversal in trauma patients receiving warfarin. Annals of Pharmacotherapy. 2011;45(7–8):869–875. doi:10.1345/aph.1P605
Sarode R, Milling TJ Jr, Refaai MA, et al. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomi- zed, plasma-controlled, phase IIIb study. Circulation. 2013;128(11):1234–1243. doi: 10.1111/ tme.12621
Wysowski DK, Nourjah P, Swartz L. Bleeding complications with warfarin use: a prevalent adver- se effect resulting in regulatory action. Archives of Internal Medicine. 2007;167(13):1414–1419. doi:10.1001/archinte.167.13.1414
Holbrook A, Schulman S, Witt DM, et al. Evidence-based management of anticoagulant therapy: Antithrombotic therapy and prevention of thrombosis, 9th edition. Chest. 2012;141(2 Supp- l):e152S–e184S. doi:10.1378/chest.11-2295
Wang K, Zhang T, Rao J, et al. Drug–drug interactions induced by linderane based on mec- hanism-based inactivation of CYP2C9 and the molecular mechanisms. Bioorganic Chemistry. 2022;118:105478. doi:10.1016/j.bioorg.2021.105478
Lippi G, Favaloro EJ. Preanalytical issues in hemostasis and thrombosis testing. Methods in Mole- cular Biology. 2017;1646:29–42. doi:10.1007/978-1-4939-7196-1_2
Ansell J, Hirsh J, Hylek E, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 Suppl):160S–198S. doi:10.1378/chest.08-0670
Berling I, Mostafa A, Grice JE, et al. Warfarin poisoning with delayed rebound toxicity. Journal of Emergency Medicine. 2017;52(2):194–196. doi:10.1016/j.jemermed.2016.05.068
Witt DM, Clark NP, Kaatz S, et al. Guidance for the practical management of warfarin the- rapy in the treatment of venous thromboembolism. Journal of Thrombosis and Thrombolysis. 2016;41(1):187–205. doi:10.1007/s11239-015-1319-y
Tomaselli GF, Mahaffey KW, Cuker A, et al. 2020 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants. Journal of the American College of Cardiology. 2020;76(5):594–622. doi:10.1016/j.jacc.2020.04.053
Milling TJ Jr, Pollack CV Jr. A review of guidelines on anticoagulation reversal across diffe- rent clinical scenarios: Is there a general consensus? American Journal of Emergency Medicine. 2020;38(9):1890–1903. doi:10.1016/j.ajem.2020.05.086
Tran HA, Chunilal SD, Harper PL, et al. An update of consensus guidelines for warfarin reversal.
Medical Journal of Australia. 2013;198(4):198–199. doi:10.5694/mja12.10614
Crowther MA, Ageno W, Garcia D, et al. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Annals of Internal Medicine. 2009;150(5):293–300. doi:10.7326/0003-4819-150-5-200903030-00005
